19-3491733-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001145165.2(DOHH):c.668C>T(p.Pro223Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000816 in 1,506,464 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000088 ( 0 hom. )
Consequence
DOHH
NM_001145165.2 missense
NM_001145165.2 missense
Scores
5
8
6
Clinical Significance
Conservation
PhyloP100: 7.29
Genes affected
DOHH (HGNC:28662): (deoxyhypusine hydroxylase) This gene encodes a metalloenzyme that catalyzes the last step in the conversion of lysine to the unique amino acid hypusine in eukaryotic initiation factor 5A. The encoded protein hydroxylates deoxyhypusine to form hypusine in the mature eukaryotic initiation factor 5A protein. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOHH | NM_001145165.2 | c.668C>T | p.Pro223Leu | missense_variant | 5/5 | ENST00000427575.6 | NP_001138637.1 | |
DOHH | NM_031304.5 | c.668C>T | p.Pro223Leu | missense_variant | 5/5 | NP_112594.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DOHH | ENST00000427575.6 | c.668C>T | p.Pro223Leu | missense_variant | 5/5 | 1 | NM_001145165.2 | ENSP00000398882.1 | ||
DOHH | ENST00000672935.1 | c.668C>T | p.Pro223Leu | missense_variant | 5/5 | ENSP00000500806.1 | ||||
DOHH | ENST00000673168.1 | n.461C>T | non_coding_transcript_exon_variant | 3/3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151842Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
151842
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000201 AC: 2AN: 99554Hom.: 0 AF XY: 0.0000359 AC XY: 2AN XY: 55722
GnomAD3 exomes
AF:
AC:
2
AN:
99554
Hom.:
AF XY:
AC XY:
2
AN XY:
55722
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000878 AC: 119AN: 1354622Hom.: 0 Cov.: 31 AF XY: 0.0000749 AC XY: 50AN XY: 667498
GnomAD4 exome
AF:
AC:
119
AN:
1354622
Hom.:
Cov.:
31
AF XY:
AC XY:
50
AN XY:
667498
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151842Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74172
GnomAD4 genome
AF:
AC:
4
AN:
151842
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74172
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:3Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
DOHH related neurodevelopmental disorder Pathogenic:2
Pathogenic, no assertion criteria provided | research | Department of Genetics, CHU d'Angers | Sep 22, 2021 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Spanish Undiagnosed Rare Disease Program-IIER, Instituto de Salud Carlos III | Aug 17, 2022 | - - |
Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 01, 2023 | The DOHH c.668C>T, p.(Pro223Leu) variant was identified in trans with a likely pathogenic variant in a patient with neurodevelopmental abnormalities (Ziegler et al 2022). Purified recombinant protein containing this variant was found to have an in-vitro enzymatic activity that was comparable to that of the wild-type protein (Ziegler et al 2022). The highest frequency of this allele in the Genome Aggregation Database is 0.000078 in the European (non-Finnish) population, with no homozygous individuals reported (version 2.1.1). Multiple lines of computational evidence are inconclusive as to whether or not this variant will impact the gene or gene product. Based on the available evidence, the c.668C>T, p.(Pro223Leu) variant is classified as a variant of uncertain significance for neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 30, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
H
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MutPred
Gain of stability (P = 0.0053);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at